|
CCT8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.58411086867727E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06257233514862E-12 |
| Normal-vs-Stage2 |
9.177600E-04 |
| Normal-vs-Stage3 |
4.45980000041146E-07 |
| Normal-vs-Stage4 |
3.80130038557525E-10 |
| Stage1-vs-Stage2 |
2.263600E-01 |
| Stage1-vs-Stage3 |
1.791240E-01 |
| Stage1-vs-Stage4 |
3.397800E-01 |
| Stage2-vs-Stage3 |
8.409600E-01 |
| Stage2-vs-Stage4 |
1.108380E-01 |
| Stage3-vs-Stage4 |
6.422300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.16350262757692E-11 |
| Normal-vs-AfricanAmerican |
2.42919999999813E-05 |
| Normal-vs-Asian |
6.76710000258041E-08 |
| Caucasian-vs-AfricanAmerican |
4.691500E-02 |
| Caucasian-vs-Asian |
2.989400E-01 |
| AfricanAmerican-vs-Asian |
2.972000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.29809957122507E-10 |
| Normal-vs-Female |
1.41830991395864E-12 |
| Male-vs-Female |
8.831400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.76647585448109E-12 |
| Normal-vs-Age(41-60Yrs) |
2.99839997275342E-09 |
| Normal-vs-Age(61-80Yrs) |
7.83720000008259E-07 |
| Normal-vs-Age(81-100Yrs) |
1.431600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.141700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.696200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.798200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.317800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.308000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.292400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.740240E-01 |
| Classical-VS-Follicular |
1.56799999984081E-07 |
| Classical-VS-Other |
7.940600E-01 |
| Classical-VS-Normal |
1.62647673107585E-12 |
| Tall-VS-Follicular |
2.227000E-04 |
| Tall-VS-Other |
4.633400E-01 |
| Tall-VS-Normal |
8.25189999997811E-07 |
| Follicular-VS-Other |
2.007400E-01 |
| Follicular-VS-Normal |
1.909680E-02 |
| Other-VS-Normal |
8.389800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.05309999796222E-08 |
| Normal-vs-N1 |
5.57449999999404E-05 |
| N0-vs-N1 |
6.274400E-01 |
|
|
